濮阳东方医院妇科很好-【濮阳东方医院】,濮阳东方医院,濮阳东方医院治疗阳痿评价非常高,濮阳东方医院看男科评价好很专业,濮阳东方看男科收费不贵,濮阳东方医院男科口碑,濮阳东方看男科非常可靠,濮阳东方妇科收费高不高

CHENGDU, May 8 (Xinhua) -- As a brand-name herbal capsule for cardiovascular disease in China, Di'ao Xinxuekang only needs to wait for another 15 years before reaching the EU market."The Dutch medical supervisors have recognized it as a qualified drug, but we still lack the evidence of 15-year presence in the EU market," said Ji Jianxin, a research manager with the drug's developer Di'ao Group based in southwest China's Sichuan Province.Di'ao, one of the largest Traditional Chinese Medicine (TCM) manufacturers, has been quite depressed, as many other TCM enterprises in China, by a European Union directive on traditional herbal medicinal products fully implemented from the beginning of this month.The directive requires that all herbal medicinal products, must obtain a medical license from any EU member state before it can be allowed in the EU market.It introduced a so-called simplified registration procedure with a seven-year transition period for traditional herbal medicinal products to be licensed, including Chinese and Indian ones.However, not a single Chinese herbal medicinal product has been granted the license so far, mainly due to the prohibitive registration cost and lack of required evidence to prove the product had a 30-year history of safe use, including 15 years in the EU.With a history of more than 2,000 years, TCM did not enter into the EU market until mid-1990s, and it has been imported into the EU and sold to European customers as food supplements instead of drugs.Most Chinese producers and importers did not reserve the customs papers a decade ago, thus unable to prove the 15-year use of their products in European markets.While TCM's globalization won't be doomed by one single EU directive as TCM export value to EU only takes up 14 percent of the total in 2010, experts and industry insiders still have had serious concerns about its future."Most TCM even don't have standardized labels that can help consumers to find out its origin," said Xian Sheng, from the China Association of TCM Export Companies.
COPENHAGEN, April 30 (Xinhua) -- As traditional Chinese medicine (known as TCM in Europe) becomes increasingly popular worldwide and has gradually been regarded as a useful component to Western medical treatments, Denmark is no stranger to such trends.According to a study published by the University of Copenhagen in mid-Feb., up to one-third of Danish hospitals choose complementary or alternative therapies, including TCM methods, to treat pain, cancer, mental disease, tumors and infertility. Acupuncture remains the most widely-practiced form of these treatments, used in some 97 percent of the cases.The nationwide acceptance of acupuncture and massage therapists, the growing ranks of herbal practitioners, and the hosting of an annual pan-Scandinavian TCM conference since 2007, all underline the popularity of alternative medicine, including the TCM, in the country.However, the overall market presence of TCM, and herbal medicines in particular, is relatively small in Denmark and Europe at large. As many European policymakers insist that traditional herbal medicines "are neither scientifically documented nor tested according to Western requirements," these treatments face difficulties in obtaining licenses and boosting sales in Europe.In fact, despite their historical pedigree and widely-accepted efficacy, TCM products are often classified as "healthcare products" or "food," rather than "drugs" in European markets.A big challenge for TCM products to gain more access to the continent is the EU's Traditional Herbal Medicinal Products Directive, which stipulates that all such products must obtain authorization if they are to be sold within the EU, starting May 1, 2011.The directive says producers must prove the product in question has been used for 30 years, 15 of which within the EU, so as to ensure its safety.While licensing is expected to be onerous and expensive, Denmark has tried to bring TCM products into the Western medical mainstream from as early as 2005. The country's well-developed biochemical and medical industry, modernized agriculture and horticulture sectors and a strong track record of cooperative research in these fields, has helped TCM's cause.For instance, Traditional Complementary Medicine Denmark, a company helping herbal product makers market their goods in Western countries, uses modern biotechnology processes and clinical trials to scientifically verify and document the efficacy of existing herbal medicines.It also advises herbal product makers on how to align their standards with European requirements so as to acquire the necessary sales licenses. Sometimes, simple solutions like clearer and more detailed labeling of a TCM product's ingredients can help improve its marketability. Patent applications and drug approvals procedures must follow, before the product can access the EU pharmaceutical market, usually in pill form.Investing in herbal medicine also makes financial sense for Denmark, as it is encourages development of low-bulk, high-value agricultural products, which can be easily transported all over the globe.Development Centre Aarslev, a Danish agro-research body and partner of TCM Denmark, studies the active ingredients contained in medicinal plants and their impact on human health conditions such as cardiovascular problems, diabetes and allergies. One of the earliest collaborations it undertook with a producer of herbal medicine showed the effectiveness of extracts from the hips of the dog rose plant in treating rheumatoid arthritis.A spokesperson for the institution said, "We have documented analytical evidence which shows that arthritis patients can reduce their consumption of conventional anti-arthritis drugs by up to 50 percent, if they combine them with the herbal drug based on dog rose hips."Given Denmark's population of 5.5 million people, this could translate into savings of 200 million U.S. dollars a year on anti-arthritis medication, the spokesperson added.Other plant-based interventions could hold wider public health benefits. TCM practitioners say herbal medicines can improve blood circulation in humans, and contain naturally-occurring antioxidants which can reduce the risks of heart attacks and better regulate cardiovascular functions. This has potentially wide-ranging benefit for Western societies, where heart disease is a major threat.Heart disease was the most common cause of death in Denmark until 2000, and cardiovascular disease the commonest until 2008, with cancer now ranking the biggest killer.In fact, TCM herbal remedies are also considered a good choice for cancer treatment, as certain plants contain hormone-like substance which can influence hormone-dependent cancers, such as breast and prostate cancer.TCM supporters say the obvious benefit of such an intervention is the avoidance of more commonly-used chemotherapy and radiation treatments which often produce severe side-effects in patients. Relevant herbal therapies can help strengthen cancer patient's immune system, reduce side-effects of chemotherapy and radiation therapy, and alleviate other symptoms of the disease.Given the many potential benefits of TCM, the EU's tightening of rules may appear harsh. Still, TCM is considered a relatively novel approach to medicine in Europe. Moreover, the dominant market share and general clout of the chemical-based, Western pharmaceutical industry also makes it difficult for traditional remedies to stake their claim.

LOS ANGELES, May 2 (Xinhua) -- An asteroid will fly past Earth this fall at a close approach that will allow a close-up view of one of Earth's good-sized space rocks, NASA's Jet Propulsion Laboratory (JPL) announced on Monday."On November 8, asteroid 2005 YU55 will fly past Earth and at its closest approach point will be about 325,000 kilometers away," said Don Yeomans, manager of NASA's Near-Earth Object Program Office at the JPL in Pasadena, Los Angeles."This asteroid is about 400 meters wide -- the largest space rock we have identified that will come this close until 2028."Despite the relative proximity and size, "YU55 poses no threat of an Earth collision over, at the very least, the next 100 years, " Yeomans said in a press release."During its closest approach, its gravitational effect on the Earth will be so miniscule as to be immeasurable. It will not affect the tides or anything else.""While near-Earth objects of this size have flown within a lunar distance in the past, we did not have the foreknowledge and technology to take advantage of the opportunity," said Barbara Wilson, a scientist at JPL. "When it flies past, it should be a great opportunity for science instruments on the ground to get a good look.""The best resolution of the radar images was 7.5 meters per pixel," said JPL radar astronomer Lance Benner. "When 2005 YU55 returns this fall, we intend to image it at 4-meter resolution with our recently upgraded equipment at the Deep Space Network at Goldstone, California. Plus, the asteroid will be seven times closer. We're expecting some very detailed radar images."Asteroid 2005 YU55 was discovered in December 2005 by Robert McMillan, head of the NASA-funded Spacewatch Program at the University of Arizona, Tucson. The space rock has been in astronomers' crosshairs before.In April 2010, Mike Nolan and colleagues at the Arecibo Observatory in Puerto Rico generated some ghostly images of 2005 YU55 when the asteroid was about 2.3 million kilometers from Earth.
WASHINGTON, April 4 (Xinhua) -- New research from the University of Pennsylvania School of Medicine has revealed an increased incidence of major adverse cardiac events (MACE), such as heart attack, stroke, and cardiovascular death, in patients with severe psoriasis. The study results were reported Monday at the annual American College of Cardiology meeting in New Orleans.Psoriasis is a common inflammatory skin disease, and if severe, has been demonstrated to be a risk factor for cardiovascular disease. However, the degree to which psoriasis is associated with MACE has not been defined.In a cohort study analyzing data from a general practice research database, Lead author Nehal Mehta, director of Inflammatory Risk in Penn's Preventive Cardiology program, and colleagues reviewed the case histories of over 3,600 patients with severe psoriasis and 14,300 controls. They found that patients with severe psoriasis have a 53 percent increased incidence of MACE compared to the general population. They also found that having a diagnosed case of severe psoriasis confers an additional ten-year risk of six percent on MACE.Previous work from Mehta and colleagues found that the risk of death from cardiovascular disease increased by 57 percent in patients with severe psoriasis. In addition, the relative risk of death from cardiovascular disease was even higher in younger patients, who were as young as age 40.The researchers conclude that this new estimate of increased ten-year MACE may warrant more aggressive strategies for treatment of cardiovascular risk factors in patients with psoriasis.
SANAA, Feb. 5 (Xinhua) -- The Somali pirates hijacked a Chinese-flagged commercial ship off Yemen's western city port of al- Hudaida in the Red Sea, Chinese military attache to Yemen confirmed to Xinhua on Saturday.The Chinese military confirmed that the Chinese-flagged commercial ship, which was registered in Hongkong, China, had been hijacked by the Somali pirates off the Yemeni coast, Chinese military attache to Yemen told Xinhua.The ship was then moved by the pirates towards the Somali coasts, he added, without providing how many people were on board or the date of the hijack.Earlier, Yemeni Interior Ministry said the Chinese ship called "Tien Hau" was attacked by the pirates some 11 nautical miles (20. 4 kilometers) off the Yemeni island of Al-Tair off the city port of al-Hudaida.Meanwhile, a security source at the ministry told Xinhua "the security operation room of the ministry received unconfirmed information that an anti-piracy international navy fleet might intercept the pirates and help release the Chinese ship.""We are following up the situation to confirm the release of the Chinese ship, as coast guard boats were dispatched to track the ship and pirates," he told Xinhua on condition of anonymity."The hijack took place early today, but we do not have exact information about the number of the ship's crew," he added.The Gulf of Aden is considered as one of the world's most dangerous waters because of rampant piracy.
来源:资阳报